Malignant Mesothelioma
Showing 26 - 50 of 61
Cervical Cancer, Fallopian Tube Cancer, Head Neck Cancer Trial run by the NCI (SS1(dsFv)-PE38 immunotoxin)
Completed
- Cervical Cancer
- +7 more
- SS1(dsFv)-PE38 immunotoxin
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Apr 29, 2015
Cervical Cancer, Fallopian Tube Cancer, Head Neck Cancer Trial in Bethesda, Winston-Salem (SS1(dsFv)-PE38 immunotoxin)
Completed
- Cervical Cancer
- +7 more
- SS1(dsFv)-PE38 immunotoxin
-
Bethesda, Maryland
- +1 more
Apr 29, 2015
Malignant Mesothelioma Trial in Belgium, France (Valproate plus doxorubicin)
Completed
- Malignant Mesothelioma
- Valproate plus doxorubicin
-
Boussu, Belgium
- +7 more
Feb 11, 2015
Malignant Mesothelioma Trial in Worldwide (bortezomib, quality-of-life assessment)
Completed
- Malignant Mesothelioma
- bortezomib
- quality-of-life assessment
-
Ghent, Belgium
- +12 more
Dec 30, 2014
Detect Mesothelioma Early in Patients Exposed to Asbestos or
Completed
- Malignant Mesothelioma
- Pulmonary Complications
- microarray analysis
- +3 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Mar 4, 2014
Malignant Mesothelioma Trial in New York (biological, drug, procedure, radiation)
Unknown status
- Malignant Mesothelioma
- recombinant interferon gamma
- +7 more
-
New York, New YorkHerbert Irving Comprehensive Cancer Center at Columbia Universit
Jan 3, 2014
Malignant Mesothelioma, Perioperative/Postoperative Complications Trial in Glasgow (quality-of-life assessment, standard
Completed
- Malignant Mesothelioma
- Perioperative/Postoperative Complications
- quality-of-life assessment
- +2 more
-
Glasgow, Scotland, United Kingdom
- +2 more
Dec 18, 2013
Breast Cancer, Endometrial Cancer, Malignant Mesothelioma Trial in Los Angeles (megestrol acetate)
Unknown status
- Breast Cancer
- +2 more
- megestrol acetate
-
Los Angeles, CaliforniaSt. Vincent Medical Center - Los Angeles
Nov 5, 2013
Malignant Mesothelioma Trial in Worldwide (doxorubicin HCl, ranpirnase)
Unknown status
- Malignant Mesothelioma
- doxorubicin hydrochloride
- ranpirnase
-
South Bend, Indiana
- +18 more
Nov 5, 2013
Malignant Mesothelioma Trial in New Orleans (PA-1-STK ovarian carcinoma vaccine, ganciclovir)
Unknown status
- Malignant Mesothelioma
- PA-1-STK ovarian carcinoma vaccine
- ganciclovir
-
New Orleans, LouisianaLouisiana State University School of Medicine
Sep 19, 2013
Malignant Mesothelioma Trial in Leeds, London, Sutton (cisplatin, mitomycin C, vincristine sulfate)
Completed
- Malignant Mesothelioma
- cisplatin
- +6 more
-
Leeds, England, United Kingdom
- +2 more
Aug 6, 2013
Malignant Mesothelioma Trial in United Kingdom (cisplatin, mitomycin C, vinblastine sulfate)
Unknown status
- Malignant Mesothelioma
- cisplatin
- +3 more
-
Hull, England, United Kingdom
- +8 more
Aug 6, 2013
Adrenocortical Carcinoma, Brain and CNS Tumors, Head Neck Cancer Trial in Ottawa (drug, procedure, radiation)
Completed
- Adrenocortical Carcinoma
- +6 more
- cisplatin
- +4 more
-
Ottawa, Ontario, CanadaOttawa Regional Cancer Centre at Ottawa Hospital - General Campu
Jul 9, 2013
Breast Cancer, Colorectal Cancer, Kidney Cancer Trial in Los Angeles (allogeneic tumor cell vaccine, autologous tumor cell
Completed
- Breast Cancer
- +5 more
- allogeneic tumor cell vaccine
- +5 more
-
Los Angeles, CaliforniaSt. Vincent Medical Center - Los Angeles
Jul 9, 2013
Malignant Mesothelioma, Metastatic Cancer Trial in United Kingdom (talc, therapeutic thoracoscopy, therapeutic
Completed
- Malignant Mesothelioma
- Metastatic Cancer
- talc
- +2 more
-
Basildon, England, United Kingdom
- +4 more
Jun 27, 2013
Malignant Mesothelioma Trial in New Brunswick, New York, Cleveland (cisplatin, pemetrexed disodium)
Completed
- Malignant Mesothelioma
- cisplatin
- pemetrexed disodium
-
New Brunswick, New Jersey
- +2 more
Jun 17, 2013
Malignant Mesothelioma Trial in Marrero, Philadelphia, Newport News (biological, drug, procedure, radiation)
Completed
- Malignant Mesothelioma
- recombinant interferon alfa
- +3 more
-
Marrero, Louisiana
- +2 more
Apr 16, 2013
Malignant Mesothelioma Trial in United States (gemcitabine HCl)
Completed
- Malignant Mesothelioma
- gemcitabine hydrochloride
-
Mobile, Alabama
- +83 more
Oct 5, 2012
Malignant Mesothelioma Trial in Siena (Tremelimumab)
Unknown status
- Malignant Mesothelioma
-
Siena, ItalyMedical Oncology and Immunotherapy Unit, University Hospital of
Jul 31, 2012
Malignant Mesothelioma Trial in Siena (Tremelimumab)
Unknown status
- Malignant Mesothelioma
-
Siena, ItalyMedical Oncology and Immunotherapy Unit, University Hospital of
Jul 20, 2012